Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Budipine is a low affinity, N-methyl-D-aspartate receptor antagonist,is an antiparkinsonian agent.
パッケージサイズ | 在庫状況 | 単価(税別) | |||
---|---|---|---|---|---|
サンプルについてお問い合わせ | |||||
5 mg | 在庫あり | ¥ 13,500 | |||
10 mg | 在庫あり | ¥ 22,500 | |||
25 mg | 在庫あり | ¥ 45,000 | |||
50 mg | 在庫あり | ¥ 85,500 | |||
100 mg | 在庫あり | ¥ 126,000 | |||
1 mL * 10 mM (in DMSO) | 在庫あり | ¥ 15,000 |
説明 | Budipine is a low affinity, N-methyl-D-aspartate receptor antagonist,is an antiparkinsonian agent. |
In vitro | The primary action of budipine is an indirect dopaminergic effect as shown by facilitation of dopamine (DA) release, inhibition of monoamine oxidase type B (MAO-B) and of DA (re) up-take and stimulation of aromatic L-amino acid decarboxylase (AADC), which in sum might be responsible for enhancing the endogenous dopaminergic activity[1]. |
分子量 | 293.45 |
分子式 | C21H27N |
CAS No. | 57982-78-2 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 2.93 mg/mL (10 mM)
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Budipine 57982-78-2 Others monoamine oxidase type B (MAO-B) inhibit CNS disorders Parkinson disease Inhibitor dopaminergic inhibitor